Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

NCT02023164 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Urticaria

Interventions

DRUG: JDP-205 Injection
DRUG: Diphenhydramine

Sponsor

JDP Therapeutics, Inc.